Investors

Date	Name	Title	Type	Shares Traded	Price Range
Jan 2, 2009	gilman alfred g	Director	Disposition (Non Open Market)	2,000	n/a
Jan 2, 2009	gilman alfred g	Director	Acquisition (Non Open Market)	2,000	n/a
Jan 2, 2009	goldberg murray a	Officer	Option Execute	1,300	7.41
Jan 6, 2009	vagelos p roy	Director	Disposition (Non Open Market)	11,771	n/a
Jan 21, 2009	gilman alfred g	Director	Option Execute	10,000	7.66
Feb 20, 2009	baker charles a	Director	Option Execute	10,000	7.66
Feb 20, 2009	baker charles a	Director	Automatic Sell	10,000	18.16
Feb 23, 2009	brown michael s	Director	Option Execute	5,000	7.66
Apr 3, 2009	vagelos p roy	Director	Disposition (Non Open Market)	14,976	n/a
Apr 27, 2009	roberts william	Officer	Option Execute	15,160	6.50
Apr 27, 2009	roberts william	Officer	Automatic Sell	15,160	12.74
Jun 23, 2009	vagelos p roy	Director	Disposition (Non Open Market)	50,384	n/a
Jun 23, 2009	vagelos p roy	Director	Acquisition (Non Open Market)	50,384	n/a
Jul 6, 2009	vagelos p roy	Director	Disposition (Non Open Market)	11,837	n/a
Jul 24, 2009	stahl neil	Officer	Option Execute	100,000	9.49
Jul 24, 2009	stahl neil	Officer	Automatic Sell	73,114	20.00 - 20.14
Jul 27, 2009	stahl neil	Officer	Automatic Sell	26,886	20.74 - 21.02
Aug 12, 2009	roberts william	Officer	Option Execute	6,666	8.50
Aug 12, 2009	roberts william	Officer	Automatic Sell	6,666	22.99
Sep 1, 2009	roberts william	Officer	Option Execute	14,166	8.50
Showing 81-100 of 627 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.